Auxilius Pharma Sp. z o.o.

Pharmacokinetics and Drug Absorption

Auxilius Pharma Sp. z o.o. is engaged in clinical research focused on pharmacokinetics and the absorption profile of an investigational extended-release capsule formulation, with attention to how the product behaves under different fasting and fed conditions in healthy subjects.

  • Drug absorption characteristics
  • Oral extended-release formulations
  • Food effect assessment

The sponsor’s research interest centers on understanding how formulation properties influence systemic exposure and bioavailability.

Cardiovascular Therapeutics

The clinical program includes work related to nicorandil, a compound associated with cardiovascular therapy and the management of angina-related treatment areas.

  • Antianginal therapy
  • Cardiac vasodilation
  • Ischemic heart disease support

Research in this domain reflects an interest in therapies used for myocardial oxygen balance and vascular function.

Healthy Volunteer Research

Auxilius Pharma Sp. z o.o. also conducts studies in healthy volunteers, supporting evaluation of tolerability and exposure patterns in individuals without diagnosed disease.

  • Normal physiological response
  • Comparative exposure conditions
  • Clinical pharmacology in non-patient populations

This area of activity aligns with clinical pharmacology research intended to characterise how a medicinal product behaves in controlled human settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Pharmacokinetics of Nicorandil 40 mg Extended‑Release Capsules in Healthy Volunteers Under Fasting and Fed Conditions

    Not recruiting

    1 1 1
    Portugal